Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Omar Habib"'
Autor:
Omar Habib Alshammari, Hasna Mohammed Al-towhere, Anwar Bstan Alanazi, Arwa Sami AlFuhaid, Khuzama Ibrahim AlMoammar, Abdullah Atef Al-Ruwaidi, Naif Hammad Alshammari, Mohamed Ali Alzain
Publikováno v:
The Journal of Medicine, Law & Public Health, Vol 3, Iss 4 (2023)
Introduction: Virtual clinics have emerged as a viable alternative to traditional face-to-face medical consultations, particularly during the COVID-19 pandemic. This study aims to evaluate the efficiency of virtual clinics by examining the satisfacti
Externí odkaz:
https://doaj.org/article/42d78678c9ec48e0a840d7176a81066d
Autor:
Agata Antepowicz, Omar Habib, Freja Kirsebom, Cecilia Johansson, Deborah R. Gill, Stephen C. Hyde
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Respiratory syncytial virus (RSV) infection is a common cause of hospitalisation in infants and the elderly. Palivizumab prophylaxis is the only approved treatment modality but is costly and only offered to select vulnerable populations. Her
Externí odkaz:
https://doaj.org/article/02a847cbdd3747d0b7746de8f6676a1b
Autor:
Han-Chung Lee, Hamizun Hamzah, Melody Pui-Yee Leong, Hadri Md Yusof, Omar Habib, Shahidee Zainal Abidin, Eryse Amira Seth, Siong-Meng Lim, Sharmili Vidyadaran, Mohamad Aris Mohd Moklas, Maizaton Atmadini Abdullah, Norshariza Nordin, Zurina Hassan, Pike-See Cheah, King-Hwa Ling
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Ruxolitinib is the first janus kinase 1 (JAK1) and JAK2 inhibitor that was approved by the United States Food and Drug Administration (FDA) agency for the treatment of myeloproliferative neoplasms. The drug targets the JAK/STAT signalling pa
Externí odkaz:
https://doaj.org/article/b2cbcfa33d8b42fb93d9fbc95b27e345
Autor:
Omar Habib, Rozita Mohd Sakri, Nadiah Ghazalli, De-Ming Chau, King-Hwa Ling, Syahril Abdullah
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244386 (2020)
CpG-free pDNA was reported to facilitate sustained transgene expression with minimal inflammation in vivo as compared to CpG-containing pDNA. However, the expression potential and impact of CpG-free pDNA in in vitro model have never been described. H
Externí odkaz:
https://doaj.org/article/1698912843ca4ef0990d46a6f2bc938b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yue Du, Kamran M Miah, Omar Habib, Helena Meyer-Berg, Catriona C Conway, Mariana A Viegas, Rebecca Dean, Dwiantari Satyapertiwi, Jincun Zhao, Yanqun Wang, Nigel J Temperton, Toby P E Gamlen, Deborah R Gill, Stephen C Hyde
Publikováno v:
Thorax. 77:1229-1236
BackgroundThe COVID-19 pandemic continues to be a worldwide threat and effective antiviral drugs and vaccines are being developed in a joint global effort. However, some elderly and immune-compromised populations are unable to raise an effective immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49b3e9155f92e16f44421988c17acda5
https://doi.org/10.1136/thoraxjnl-2021-217650
https://doi.org/10.1136/thoraxjnl-2021-217650
Autor:
null Patricia P. Ogger, null Minerva Garcia Martín, null Christina Michalaki, null Jie Zhou, null Jonathan C. Brown, null Yue Du, null Kamran M. Miah, null Omar Habib, null Stephen C. Hyde, null Deborah R. Gill, null Wendy S. Barclay, null Cecilia Johansson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab2b52f860cd194835530db57e0768f4
https://doi.org/10.1002/eji.202249913/v3/response1
https://doi.org/10.1002/eji.202249913/v3/response1
Autor:
Siong Meng Lim, Sharmili Vidyadaran, Han-Chung Lee, Maizaton Atmadini Abdullah, Shahidee Zainal Abidin, Hadri Yusof, Norshariza Nordin, Zurina Hassan, Eryse Amira Seth, King Hwa Ling, Hamizun Hamzah, Omar Habib, Pike See Cheah, Melody Pui-Yee Leong, Mohamad Aris Mohd Moklas
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports
Scientific Reports
Ruxolitinib is the first janus kinase 1 (JAK1) and JAK2 inhibitor that was approved by the United States Food and Drug Administration (FDA) agency for the treatment of myeloproliferative neoplasms. The drug targets the JAK/STAT signalling pathway, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663930b4bf2f753b3649f45f912976af
https://doi.org/10.1038/s41598-021-83222-z
https://doi.org/10.1038/s41598-021-83222-z
Publikováno v:
Design and Construction of Smart Cities ISBN: 9783030642167
Tolerance in the construction industry has been regarded as a vague topic due to the paucity of information available on it. As a result, the effect of tolerance and its impact on a project has been neglected in many cases. This impact can sometimes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0aad81f57d68c303f2ee900819dafae
https://doi.org/10.1007/978-3-030-64217-4_14
https://doi.org/10.1007/978-3-030-64217-4_14